Weibo Wu
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
-
- Inflammasome and immune disorders 2
- Co-authors
- Caiming Chen (2 shared papers)Jianfeng Chen (1 shared paper)Yingxia Liu (7 shared papers)Mengli Cao (5 shared papers)Fuxiang Wang (4 shared papers)Chuming Chen (6 shared papers)Shengcun Li (1 shared paper)Songhe Jiang (1 shared paper)
- Journals
- Frontiers in Oncology (1 paper)Microbiology Spectrum (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)International Immunopharmacology (1 paper)BMJ Open (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Weibo Wu
13 papers receiving 214 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 46
- Health Informatics 3
- Pharmacology 19
- Molecular Medicine 10
- Neurology 15
Countries citing papers authored by Weibo Wu
This map shows the geographic impact of Weibo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Wu more than expected).
Fields of papers citing papers by Weibo Wu
This network shows the impact of papers produced by Weibo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Wu. The network helps show where Weibo Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 86 | |
| 2 | 2020 | 34 | |
| 3 | 2020 | 22 | |
| 4 | 2020 | 22 | |
| 5 | 2023 | 13 | |
| 6 | 2018 | 12 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 6 | |
| 9 | 2023 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2025 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 0 | |
| 15 | 2022 | 0 |
About Weibo Wu
Weibo Wu is a scholar working on Infectious Diseases, Molecular Biology, Neurology, Oncology and Epidemiology, having authored 15 papers that have together received 217 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers), Inflammasome and immune disorders (2 papers), Respiratory Support and Mechanisms (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Immune responses and vaccinations (1 paper) and COVID-19 Impact on Reproduction (1 paper). The work is most often cited by research in Infectious Diseases (46 citations), Health Informatics (3 citations), Pharmacology (19 citations), Molecular Medicine (10 citations) and Neurology (15 citations). Weibo Wu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Caiming Chen, Jianfeng Chen, Yingxia Liu, Mengli Cao, Fuxiang Wang, Chuming Chen, Shengcun Li, Songhe Jiang, Qian Wang and Yang Xu. Their work appears in journals such as Frontiers in Oncology, Microbiology Spectrum, Journal of Pharmaceutical and Biomedical Analysis, International Immunopharmacology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.